Eriacta 100mg - Viagra by Ranbaxy

Eriacta 100mg - Viagra by Ranbaxy View full size
Price:

$29.95

100mg - 12 tablets
100mg - 24 tablets
100mg - 48 tablets

Eriacta is, used for the treatment of pulmonary arterial hypertension and erectile dysfunction. Scientists Andrew Bell, David Brown, and Nicholas Terrett from Pfizer first discovered the drug. It works through inhibition of cGMP-specific phosphodiesterase type 5 (PDE5

More details
Ask a question (0)

Eriacta 100mg - Viagra by Ranbaxy

Eriacta 100mg - Viagra by Ranbaxy Eriacta like Viagra is ED medicine with active ingredient sildenafil citrate.It is a well known medication that stimulates blood flow to the penis.
  • More info
  • Reviews (0)
  • Questions (0)
  • Articles

Eriacta is, used for the treatment of pulmonary arterial hypertension and erectile dysfunction. Scientists Andrew Bell, David Brown, and Nicholas Terrett from Pfizer first discovered the drug. It works through inhibition of cGMP-specific phosphodiesterase type 5 (PDE5). This is an enzyme that carries forward cGMP degradation, which in turn regulates blood flow in the penis. It has been launched in 1998 and along with tadalafil and vardenafil are the most used drugs for the treatment of erectile dysfunction.

Eriacta

Qualitative and quantitative composition: Each film coated tablet of Eriacta contains 25, 50 or 100 mg sildenafil citrate equivalent to the same amount of sildenafil. The coat further contains 0.834, 1.667 and 3.334 mg of lactose (as monohydrate) respectively.

Pharmacological action: Eriacta works through inhibition of cGMP-specific phosphodiesterase type 5 (PDE5). This is an enzyme that carries forward cGMP degradation, which in turn regulates blood flow in the penis. But it cannot work without sexual stimulation and cannot be used to increase libido.

Therapeutic indications: Eriacta is indicated for the treatment of erectile dysfunction in adult men who cannot maintain sufficient penile erection for satisfactory sexual performance. For Eriacta to work sexual stimulation is necessary. It cannot be used in adult women and children and it does not increase the libido.

Contraindications: Eriacta cannot be given to patients having hypersensitivity to it. Further, it has hypotensive effects of nitrates thus cannot be co-administered with nitric oxide donors. It should not be administered in patient with severe cardiac disorder and others who had been advised against sexual activity.

Eriacta is also contraindicated in patients suffering from loss of vision in one eye due to non-arteritic anterior ischaemic optic neuropathy (NAION). Effect of Eriacta is still not fully of stroke, and hereditary retinal disorder.

Special warnings and precautions for use: Administration of Eriacta should be done with caution if the patient has cardiovascular risk factors. Severe cardiovascular problems have been noted after use of Eriacta (cerebrovascular haemorrhage, myocardial infarction, sudden cardiac death, ventricular arrhythmia, transient ischaemic attack, hypertension and hypotension, unstable angina).

Patients suffering from priapism and anatomical deformation (cavernosal fibrosis, angulation or Peyronie's disease) of the penis proper treatment should be done instead of using Eriacta as it may cause permanent loss of sexual potency. Prolonged erections are another aspect that need to be monitored and if erection persists for more than four hours immediate assistance of doctors should be taken.

It has hypotensive effects of nitrates thus cannot be coadministered with nitric oxide donors. Concomitant use with other PDE5 inhibitors or other treatments for erectile dysfunction and, with ritonavir, alpha blockers (can have systematic hypotension) is not advisable. Eriacta is also contraindicated in patients suffering from loss of vision in one eye due to non-arteritic anterior ischaemic optic neuropathy (NAION). Eriacta can also cause peptic ulcer and bleeding disorder, though no specific case has been reported. The coating contains lactose, so cannot be used for patients suffering from galactose intolerance. Eriacta is not for adult women and children.

Interaction with other medicinal products: Inhibitors of cytochrome P450 (CYP) isoforms 3A4 (major route) and 2C9 (minor route) through which metabolism of Eriacta takes place, can cause reduction in the rate of Eriacta clearance. Similarly inducers of these isoenzymes will increase clearance of Eriacta.

Nicorandil (hybrid of potassium channel activator and nitrate) can cause severe interaction with Eriacta because of the nitrate component.

Eriacta, including antacids (aluminium or magnesium hydroxide); Dipyridamole/ theophylline (non-specific phosphodiesterase inhibitors); tolbutamide; warfarin; acetyl salicylic acid; HIV protease inhibitors (ritonavir/ saquinavir) have no direct interaction with Eriacta and do not hamper the bioavailability of Eriacta. Eriacta is also not affected by consumption of alcohol as per studies made (up to 80 mg/dl alcohol levels in blood).

Undesirable effects: Patients treated with Eriacta have several adverse reactions that may include blurred vision, dizziness, nasal congestion, hot flush, headache, cyanopsia, nausea, and dyspepsia.

Interesting facts:

  • Eriacta is an amazingly successful drug and the fastest selling drug yet (around $2 billion sales).
  • Though Eriacta is very effective in getting erection in the presence of sexual stimuli, it cannot increase the libido.

No customer reviews for the moment.

Add Review
hide form
Rating:
Name:
Email:
Subject:
Text:
  Add review

No customer questions for the moment.

Ask a question
Your Question has been successfully sent our team. Thanks for question!
Ask a question
hide form
Name:
Email:
Question:
  Ask a question